Artificial Intelligence (AI)-Enhanced Ultrasound Techniques Used in Non-Alcoholic Fatty Liver Disease: Are They Ready for Prime Time?

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic disease, affecting approximately 2 billion individuals worldwide with a spectrum that can range from simple steatosis to cirrhosis. Typically, diagnosis NAFLD based on imaging studies, but gold standard remains biopsies. Hence, use artificial intelligence (AI) in this field, which has recently undergone rapid development various aspects medicine, potential accurately diagnose and steatohepatitis (NASH). This paper provides an overview latest research employs AI for staging NAFLD, as well applications future developments field.